Ardian-owned Laboratoires Anios acquires Soluscope

Laboratoires Anios, which is owned by Ardian, has acquired Soluscope. No financial terms were disclosed. Based in Aubagne, France, Soluscope is a maker of washer-disinfectors for endoscopes used in hospitals.


April 30th 2014. Laboratoires Anios, a leading European provider of disinfection for hospitals and clinics, and a key actor for industrial and collectivity players, today announces the acquisition of the French company Soluscope.
This is the first acquisition made by the consortium composed of Bertrand Letartre, Thierry Letartre and Ardian, the premium independent private investment company, since it acquired Laboratoires Anios in December 2013.
Based in Aubagne (South of France) and founded in 1994 by Frédéric Dray and Bernard Mariotti, Soluscope designs and manufactures washer-disinfectors for flexible endoscopes used in hospitals. Such acquisition allows Laboratoires Anios to strengthen its position in high-end disinfection segments and to broaden its offer in endoscope automatic reprocessing, now proposing a global chemistry and equipment offer.
The combination allows both companies to consolidate their position in France, capitalize on their complementary global network, while offering an integrated solution to their clients.
Soluscope, which has been a business partner of Laboratoires Anios since 2001, also offers storage and dedicated IT solutions to optimize the traceability of endoscope reprocessing. With 132 employees, the company operates in more than 60 countries. In 2013, it generated a turnover of €23 million, almost 50% of which abroad. On a consolidated basis, the Anios Group will achieve a turnover of €200 million.
Bertrand and Thierry Letartre, respectively CEO and Managing Director of Laboratoires Anios, said: “This acquisition is consistent with our external growth strategy and extends our conquering ambitions to endoscopy, by reinforcing and supplementing our business in this segment in France and abroad.”
Philippe Poletti, head of Mid Cap Buyout activity at Ardian, added: “The active support and financial resources provided for this combination highlight our common ambition to accelerate Anios’ development in France and abroad in its key segments.”
N°1 in France and European leader in the disinfection market. Laboratoires Anios manufactures cleaning and disinfection products since 1898, and is a major player in hygiene, for hospitals, clinics and medical professions. Laboratoires Anios is also present in food-processing, cosmetics, and pharmaceutics industries, as well as in the communities linked to accommodation and catering, in France and in over 80 countries. With 450 employees, two production sites and a 1,000 square meters research center in northern France, Laboratoires Anios produces 120,000 bottles per day and has 12,000 business customers.
Soluscope employs 132 employees and is the only European company fully specialized in the reprocessing of flexible endoscopes which offers a complete solution including dedicated automated chemical disinfection, transport, drying and storage solutions, as well as data management tools. The fleet of over 3,800 devices worldwide, positions Soluscope as market leader in France, Spain, Italy, and Australia / New Zealand.
Founded in 1996 and led by Dominique Senequier, Ardian is a premium independent private investment company with assets of US$47bn managed or advised in Europe, North America and Asia.
The company, which is majority-owned by its employees, keeps entrepreneurship at its heart and delivers investment performance to its global investors while fuelling growth in economies across the world. Ardian’s investment process blends discipline and conviction with a long-term philosophy.
Ardian maintains a truly global network, with more than 330 employees working through ten offices in Beijing, Frankfurt, Jersey, London, Luxembourg, Milan, New York, Paris, Singapore, and Zurich. The company offers its 302 investors a diversified choice of funds covering the full range of asset classes, including Funds of Funds (primary, early secondary and secondary), Direct Funds including Infrastructure, Expansion, Mid Cap Buyout, Innovation & Growth, Co-Investment and Private Debt.